Загрузка...
Treatment of systemic-onset juvenile arthritis with canakinumab
Treatment of systemic-onset juvenile idiopathic arthritis is challenging, but the availability of cytokine antagonists targeting interleukin-1 and interleukin-6 have markedly advanced the therapeutic options. In this review, we focus on the current experience with canakinumab, an interleukin-1 monoc...
Сохранить в:
| Опубликовано в: : | Open Access Rheumatol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045123/ https://ncbi.nlm.nih.gov/pubmed/27790042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S54215 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|